Two years after a high-frequency version of Nevro’s neurostimulation system became the first spinal cord stimulator approved by the FDA with a specific indication to treat pain associated with ...

The neurostimulation company Nevro has secured a new FDA approval for its chronic pain treatment device, aimed at patients suffering from nerve damage associated with diabetes. The agency’s ...

Nevro Corp. NVRO recently announced preliminary revenues for second-quarter 2021. The company expects to release detailed financial results for the period on Aug 4. As per the preliminary report ...

Boston Scientific won $20 million in patent case against Nevro last year Two related trials were scheduled for next year (Reuters) - Medical-device maker Boston Scientific Corp has agreed to pay ...